Back to Results
First PageMeta Content
Ribbon symbolism / Apoptosis / P53 / Spindle checkpoint / RNA interference / Cancer research / BUB1 / Breast cancer / NUMB / Biology / Tumor suppressor genes / Gene expression


From a Natural Product to a Fully Synthetic Clinical Development Candidate
Add to Reading List

Document Date: 2014-07-16 05:07:53


Open Document

File Size: 2,95 MB

Share Result on Facebook

City

Berlin / /

Company

Onkologie Berlin-Buch GmbH / ABC / Pharmakologie & Onkologie Berlin-Buch GmbH / /

Country

Germany / /

/

Facility

Scale bar / A B C D E F Scale bar / /

IndustryTerm

treatment of the tumor disease / cancer therapy / tumor tissue bank / molecular and chemical knowledge / pharmaceutical / imaging / /

MedicalCondition

preclinical translational cancer / tumor / cancer / tumors / disease / NSCLC / metastasis / extensively characterized tumor / vivo tumor / patient-derived tumor / tumor progression / colon cancer / tumor disease / lung cancer / low frequency disease / lowly predictive preclinical tumor / preclinical cancer / A549 lung cancer / Metastases / breast cancer / /

MedicalTreatment

chemotherapy / chemotherapies / cancer therapy / /

Organization

U.S. Food and Drug Administration / /

Person

Chin Clin Oncol / Jens Hoffmann / /

Position

Representative / /

Product

paclitaxel / /

ProvinceOrState

South Dakota / /

Technology

pharmacokinetics / bioinformatics / drug discovery / genetic engineering / siRNA / antibodies / gene expression / polymerization / chemotherapy / treating cancer / cloning / pharmacodynamics / RNAi screening technology / siRNA technology / drug development / apoptosis / /

URL

http /

SocialTag